Similarly, FOXO3 upregulation is associated with poor outcomes in AML, glioblastoma, pancreatic ductal adenocarcinoma, and breast and colorectal cancers [53,54,55,56,57]. The gene discussed is FOXO3; the disease is colorectal cancer.